10 No. 3 ANHLLR 1Andrews Health Law Litigation Reporter (Approx. 3 pages)
10 No. 3 Andrews Health L. Litig. Rep. 1
Andrews Health Law Litigation Reporter
September 13, 2002
Copyright (c) 2002 Andrews Publications
FTC REPORT RECOMMENDS CHANGES TO HATCH-WAXMAN ACT
Generic Drug Entry Prior to Patent Expiration
Generic drugs make up an ever-increasing share of the prescription drug market, but some changes to the Hatch-Waxman Act would further streamline the approval process for generics and make it more difficult for brand-name and generic manufacturers to...